2022 CMT Patient and Research Summit Bios Final

…nursery. He also resuscitates newborns when needed during high-risk deliveries. At the Fetal Treatment Center, he provides prenatal counseling to women with complicated pregnancies. Judge’s research focuses on genetic diseases…

CMTA_2014_Form_990

…drug testing in a transgenic rat model aimed at developing diagnostic applications and/or a pharmacological treatment of CMT1A disease. Region: Europe (d) Purpose of Grant: To conduct experimental therapy trial…

CMTA_2019-2020_Audited_Financial_Statements

…and supports research into the cause, treatment and cure of CMT disorders. The Association also facilitates education and support for persons affected by CMT disorders. (2) SUMMARY OF SIGNIFICANT ACCOUNTING…

2021Sanders

…support, public education, promotion of research and ultimately treatments for and the cure of CMT. MAIL IN DONATIONS (USE THE ENCLOSED ENVELOPE), OR, SUBMIT FORM TO: CMTA, PO BOX 105,…

GAN Community Letter 31JAN2022 Final

…treatment of giant axonal neuropathy (GAN). The trial is being conducted by the National Institute of Neurological Disorders and Stroke (NINDS) division of the National Institutes of Health (NIH). This…

CMT-and-Genetic-Testing-Why-Is-It-Important

…process, so if a test is available, it can lead to earlier diagnosis. Finally, genetic diagnosis may help direct treatments and similarly can discontinue ineffective treatments and focus on ones…

TMJulia_23

…Accelerate Research (CMTA-STAR), our initiative which is striving to find effective treatments for CMT, we are also doing everything we can at the CMTA to ensure a brighter future for…

Taysha Letter to the GAN Community – 9.19.2023

…treatment of giant axonal neuropathy (GAN). This decision follows the receipt of feedback from the United States (U.S.) Food and Drug Administration (FDA) regarding a registrational path for TSHA-120. FDA…

Type1_Research_Developments_6-2020

As part of this multi-pronged approach to identifying novel treatments for demyelinating CMT, the CMTA is supporting several promising therapeutic opportunities in collaboration with more than a dozen key partners:…

Type2_Research_Developments_6-2020

…stem cells to develop assays and test additional libraries of drugs for treatment in CMT2E. ● We are supporting work in Dr. Ron Liem’s lab at Columbia University to screen…